|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.86 AED | -.--% |
|
+21.02% | +21.02% |
| 02-05 | MBME Group Logs Higher FY25 Preliminary Net Profit | MT |
| 02-04 | MBME GROUP Private Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2022 | 2023 (AED) | 2024 (AED) |
|---|---|---|---|
Profitability | |||
Return on Assets | - | -0.13 | -0.17 |
Return on Total Capital | - | -0.13 | -0.17 |
Return On Equity % | - | 7.62 | 1.45 |
Return on Common Equity | - | 7.62 | 1.45 |
Margin Analysis | |||
Gross Profit Margin % | - | - | 100 |
SG&A Margin | - | - | 3.37K |
EBITDA Margin % | - | - | -3.39K |
EBITA Margin % | - | - | -3.46K |
EBIT Margin % | - | - | -3.46K |
Income From Continuing Operations Margin % | - | - | 18.3K |
Net Income Margin % | - | - | 18.3K |
Net Avail. For Common Margin % | - | - | 18.3K |
Normalized Net Income Margin | - | - | -1.92K |
Levered Free Cash Flow Margin | - | - | 84.38K |
Unlevered Free Cash Flow Margin | - | - | 84.39K |
Asset Turnover | |||
Asset Turnover | - | - | 0 |
Fixed Assets Turnover | - | - | 0.21 |
Receivables Turnover (Average Receivables) | - | - | 0 |
Short Term Liquidity | |||
Current Ratio | 0.31 | 12.67 | 1.41 |
Quick Ratio | 0.31 | 12.65 | 1.19 |
Operating Cash Flow to Current Liabilities | 1.62 | -12.46 | -0.41 |
Days Sales Outstanding (Average Receivables) | - | - | 162K |
Long Term Solvency | |||
Total Debt/Equity | 0.01 | 0.02 | 0.02 |
Total Debt / Total Capital | 0.01 | 0.02 | 0.02 |
LT Debt/Equity | - | 0.01 | 0.01 |
Long-Term Debt / Total Capital | - | 0.01 | 0.01 |
Total Liabilities / Total Assets | 1.43 | 0.63 | 0.69 |
EBIT / Interest Expense | - | -333.2 | -307.15 |
EBITDA / Interest Expense | - | -327.8 | -290.17 |
(EBITDA - Capex) / Interest Expense | - | -354 | -302.19 |
Total Debt / EBITDA | -0.07 | -0.13 | -0.06 |
Net Debt / EBITDA | 5.71 | 5.56 | 2.56 |
Total Debt / (EBITDA - Capex) | -0.07 | -0.12 | -0.06 |
Net Debt / (EBITDA - Capex) | 5.71 | 5.14 | 2.46 |
Growth Over Prior Year | |||
EBITDA, 1 Yr. Growth % | - | 362.09 | 35.21 |
EBITA, 1 Yr. Growth % | - | 344 | 37.83 |
EBIT, 1 Yr. Growth % | - | 344 | 37.83 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 8.92 | -79.93 |
Net Income, 1 Yr. Growth % | - | 8.92 | -79.93 |
Normalized Net Income, 1 Yr. Growth % | - | 268.21 | 16.65 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | 7.38 | 115.11 |
Accounts Receivable, 1 Yr. Growth % | - | - | -98.54 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 451.84 | -11.03 |
Total Assets, 1 Yr. Growth % | - | 17.16 | -5.26 |
Tangible Book Value, 1 Yr. Growth % | - | 18.12 | -5.31 |
Common Equity, 1 Yr. Growth % | - | 18.12 | -5.31 |
Cash From Operations, 1 Yr. Growth % | - | -765.17 | -73.16 |
Capital Expenditures, 1 Yr. Growth % | - | - | -31.39 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | -185.11 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | -185.12 |
Compound Annual Growth Rate Over Two Years | |||
EBITDA, 2 Yr. CAGR % | - | - | 149.95 |
EBITA, 2 Yr. CAGR % | - | - | 147.38 |
EBIT, 2 Yr. CAGR % | - | - | 147.38 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | -53.25 |
Net Income, 2 Yr. CAGR % | - | - | -53.25 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 102.4 |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | 51.98 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 121.58 |
Total Assets, 2 Yr. CAGR % | - | - | 5.36 |
Tangible Book Value, 2 Yr. CAGR % | - | - | 5.76 |
Common Equity, 2 Yr. CAGR % | - | - | 5.76 |
Cash From Operations, 2 Yr. CAGR % | - | - | -52.18 |
- Stock Market
- Equities
- MBME Stock
- Financials MBME GROUP Private
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















